{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:43Z","timestamp":1792787863239,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06382-9","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T13:10:03Z","timestamp":1764421803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Insights into SUMOylation in gastric cancer: molecular mechanisms and emerging therapeutic opportunities"],"prefix":"10.1007","volume":"152","author":[{"given":"Peyman","family":"Tabnak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ebrahimnezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"6382_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1021\/acscentsci.1c01490","volume":"8","author":"G Akimoto","year":"2022","unstructured":"Akimoto G, Fernandes AP, Bode JW (2022) Site-specific protein ubiquitylation using an engineered, chimeric E1 activating enzyme and E2 SUMO conjugating enzyme Ubc9. ACS Cent Sci 8:275\u2013281","journal-title":"ACS Cent Sci"},{"key":"6382_CR2","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1038\/s41388-021-01963-7","volume":"40","author":"A-M Birladeanu","year":"2021","unstructured":"Birladeanu A-M, Rogalska M, Potiri M, Papadaki V, Andreadou M, Kontoyiannis DL et al (2021) The scaffold protein IQGAP1 links heat-induced stress signals to alternative splicing regulation in gastric cancer cells. Oncogene 40:5518\u20135532. https:\/\/doi.org\/10.1038\/s41388-021-01963-7","journal-title":"Oncogene"},{"key":"6382_CR3","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.2174\/0929867327666200810135039","volume":"28","author":"CM Brackett","year":"2021","unstructured":"Brackett CM, Blagg BSJ (2021) Current status of SUMOylation inhibitors. Curr Med Chem 28:3892\u20133912","journal-title":"Curr Med Chem"},{"key":"6382_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"6382_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04478-w","author":"A Calderon-Rivera","year":"2024","unstructured":"Calderon-Rivera A, Gomez K, Rodr\u00edguez-Palma EJ, Khanna R (2024) SUMOylation and DeSUMOylation: tug of war of pain signaling. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04478-w","journal-title":"Mol Neurobiol"},{"key":"6382_CR6","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen AB, Sahin U (2020) Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J 287:3110\u20133140. https:\/\/doi.org\/10.1111\/febs.15319","journal-title":"FEBS J"},{"key":"6382_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21775\/cimb.035.017","volume":"35","author":"S Chen","year":"2020","unstructured":"Chen S, Dong D, Xin W, Zhou H (2020a) Progress in the discovery of small molecule modulators of desumoylation. Curr Issues Mol Biol 35:17\u201334","journal-title":"Curr Issues Mol Biol"},{"key":"6382_CR8","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41419-020-2718-3","volume":"11","author":"C Chen","year":"2020","unstructured":"Chen C, Sun X, Xie W, Chen S, Hu Y, Xing D et al (2020b) Opposing biological functions of the cytoplasm and nucleus DAXX modified by SUMO-2\/3 in gastric cancer. Cell Death Dis 11:514. https:\/\/doi.org\/10.1038\/s41419-020-2718-3","journal-title":"Cell Death Dis"},{"key":"6382_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000765","author":"L Du","year":"2021","unstructured":"Du L, Liu W, Rosen ST (2021) Targeting SUMOylation in cancer. Curr Opin Oncol. https:\/\/doi.org\/10.1097\/CCO.0000000000000765","journal-title":"Curr Opin Oncol"},{"key":"6382_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1240115","author":"H Dutta","year":"2023","unstructured":"Dutta H, Jain N (2023) Post-translational modifications and their implications in cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1240115","journal-title":"Front Oncol"},{"key":"6382_CR11","doi-asserted-by":"publisher","first-page":"e3144","DOI":"10.1038\/cddis.2017.528","volume":"8","author":"S Fang","year":"2017","unstructured":"Fang S, Hong H, Li L, He D, Xu Z, Zuo S et al (2017) Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1\u03b1 and GRP78. Cell Death Dis 8:e3144\u2013e3144. https:\/\/doi.org\/10.1038\/cddis.2017.528","journal-title":"Cell Death Dis"},{"key":"6382_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40164-023-00420-3","volume":"12","author":"Y Gu","year":"2023","unstructured":"Gu Y, Fang Y, Wu X, Xu T, Hu T, Xu Y et al (2023) The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. Exp Hematol Oncol 12:58. https:\/\/doi.org\/10.1186\/s40164-023-00420-3","journal-title":"Exp Hematol Oncol"},{"key":"6382_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101136","volume":"77","author":"Y Gu","year":"2024","unstructured":"Gu Y, Xu T, Fang Y, Shao J, Hu T, Wu X et al (2024) Cbx4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation. Drug Resist Updat 77:101136. https:\/\/doi.org\/10.1016\/j.drup.2024.101136","journal-title":"Drug Resist Updat"},{"key":"6382_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/cac2.12367","volume":"42","author":"J Han","year":"2022","unstructured":"Han J, Nie M, Chen C, Cheng X, Guo T, Huangfu L et al (2022) SDCBP-AS1 destabilizes \u03b2-catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis. Cancer Commun 42:1141\u20131161. https:\/\/doi.org\/10.1002\/cac2.12367","journal-title":"Cancer Commun"},{"key":"6382_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/CBM-170651","volume":"21","author":"X-Y Hu","year":"2018","unstructured":"Hu X-Y, Liu Z, Zhang K-L, Feng J, Liu X-F, Wang L-Y et al (2018) SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells. Cancer Biomark 21:195\u2013201","journal-title":"Cancer Biomark"},{"key":"6382_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen C, Tong X, Chen S, Hu X, Pan B et al (2021) NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis 12:842. https:\/\/doi.org\/10.1038\/s41419-021-04127-3","journal-title":"Cell Death Dis"},{"key":"6382_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s13402-022-00722-4","volume":"45","author":"G Huang","year":"2022","unstructured":"Huang G, Cai G, Hu D, Li J, Xu Q, Chen Z et al (2022) Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition. Cell Oncol 45:1329\u20131346. https:\/\/doi.org\/10.1007\/s13402-022-00722-4","journal-title":"Cell Oncol"},{"key":"6382_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2055","author":"Y Jiao","year":"2024","unstructured":"Jiao Y, Zhang X, Yang Z (2024) SUMO\u2010specific proteases: SENPs in oxidative stress\u2010related signaling and diseases. BioFactors. https:\/\/doi.org\/10.1002\/biof.2055","journal-title":"BioFactors"},{"key":"6382_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1159\/000460836","volume":"41","author":"L Jin","year":"2017","unstructured":"Jin L, Shen K, Chen T, Yu W, Zhang H (2017) SUMO-1 gene silencing inhibits proliferation and promotes apoptosis of human gastric cancer SGC-7901 cells. Cell Physiol Biochem 41:987\u2013998. https:\/\/doi.org\/10.1159\/000460836","journal-title":"Cell Physiol Biochem"},{"key":"6382_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6291656","volume":"2022","author":"C Ke","year":"2022","unstructured":"Ke C, Xiaowen C, Yufeng W, Dongchang L, Huaqing Z, Zhengguang W (2022) Posttranslational modifications of Rev-Erb\u03b1 protein and abnormal inflammatory response in gastric cancer. J Oncol 2022:6291656. https:\/\/doi.org\/10.1155\/2022\/6291656","journal-title":"J Oncol"},{"key":"6382_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.13005\/bbra\/3203","volume":"21","author":"RR Kolgi","year":"2024","unstructured":"Kolgi RR, Bhargavi G, Angaswamy N, Srinivasulu MV, Somashetty S (2024) A short review-biochemical aspects and advancements in gastric cancer. Biosci Biotechnol Res Asia 21:69\u201379","journal-title":"Biosci Biotechnol Res Asia"},{"key":"6382_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174402","author":"A Kukkula","year":"2021","unstructured":"Kukkula A, Ojala VK, Mendez LM, Sistonen L, Elenius K, Sundvall M (2021) Therapeutic potential of targeting the SUMO pathway in cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13174402","journal-title":"Cancers (Basel)"},{"key":"6382_CR23","first-page":"682","volume":"8","author":"J Li","year":"2015","unstructured":"Li J, Cui J, Zhang J, Liu Y, Han L, Jia C et al (2015) PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer. Int J Clin Exp Med 8:682","journal-title":"Int J Clin Exp Med"},{"key":"6382_CR24","doi-asserted-by":"publisher","first-page":"6180","DOI":"10.1038\/s41388-021-02011-0","volume":"40","author":"B Li","year":"2021","unstructured":"Li B, Xia Y, Lv J, Wang W, Xuan Z, Chen C et al (2021) MiR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche. Oncogene 40:6180\u20136194. https:\/\/doi.org\/10.1038\/s41388-021-02011-0","journal-title":"Oncogene"},{"key":"6382_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109585","volume":"125","author":"J-R Liang","year":"2020","unstructured":"Liang J-R, Yang H (2020) Ginkgolic acid (GA) suppresses gastric cancer growth by inducing apoptosis and suppressing STAT3\/JAK2 signaling regulated by ROS. Biomed Pharmacother 125:109585. https:\/\/doi.org\/10.1016\/j.biopha.2019.109585","journal-title":"Biomed Pharmacother"},{"key":"6382_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.clinre.2010.12.002","volume":"35","author":"L Liu","year":"2011","unstructured":"Liu L, Yan M, Yang D, Sun W, Zhang J (2011) Pias3 expression in human gastric carcinoma and its adjacent non-tumor tissues. Clin Res Hepatol Gastroenterol 35:393\u2013398. https:\/\/doi.org\/10.1016\/j.clinre.2010.12.002","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"6382_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/s41418-018-0259-4","volume":"26","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang Q, Ruan B, Chen W, Zheng J, Xu B et al (2019) MORC2 regulates C\/EBP\u03b1-mediated cell differentiation via sumoylation. Cell Death Differ 26:1905\u20131917. https:\/\/doi.org\/10.1038\/s41418-018-0259-4","journal-title":"Cell Death Differ"},{"key":"6382_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2021.01.007","volume":"516","author":"W Liu","year":"2021","unstructured":"Liu W, Zeng M, Fu N (2021a) Functions of nuclear receptors SUMOylation. Clin Chim Acta 516:27\u201333","journal-title":"Clin Chim Acta"},{"key":"6382_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2021.109394","volume":"337","author":"D Liu","year":"2021","unstructured":"Liu D, Li Z, Yang Z, Ma J, Mai S (2021b) Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R. Chem Biol Interact 337:109394. https:\/\/doi.org\/10.1016\/j.cbi.2021.109394","journal-title":"Chem Biol Interact"},{"key":"6382_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13578-022-00756-z","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Wang Q, Kang Y, Xu S, Pang D (2022) Unconventional protein post-translational modifications: the helmsmen in breast cancer. Cell Biosci 12:22. https:\/\/doi.org\/10.1186\/s13578-022-00756-z","journal-title":"Cell Biosci"},{"key":"6382_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12935-023-03062-x","volume":"23","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu J, Peng N, Hai S, Zhang S, Zhao H et al (2023) Role of non-canonical post-translational modifications in gastrointestinal tumors. Cancer Cell Int 23:225. https:\/\/doi.org\/10.1186\/s12935-023-03062-x","journal-title":"Cancer Cell Int"},{"key":"6382_CR32","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.7150\/jca.20587","volume":"8","author":"Y Luo","year":"2017","unstructured":"Luo Y, You S, Wang J, Fan S, Shi J, Peng A et al (2017) Association between sumoylation-related gene rs77447679 polymorphism and risk of gastric cancer (GC) in a Chinese population. J Cancer 8:3226","journal-title":"J Cancer"},{"key":"6382_CR33","doi-asserted-by":"publisher","first-page":"18114","DOI":"10.1021\/acs.jmedchem.1c01609","volume":"64","author":"A Luxenburger","year":"2021","unstructured":"Luxenburger A, Bougen-Zhukov N, Fraser MG, Beetham H, Harris LD, Schmidt D et al (2021) Discovery of AL-GDa62 as a potential synthetic lethal lead for the treatment of gastric cancer. J Med Chem 64:18114\u201318142. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01609","journal-title":"J Med Chem"},{"key":"6382_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X Ma","year":"2023","unstructured":"Ma X, Jia S, Wang G, Liang M, Guo T, Du H et al (2023) TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal Transduct Target Ther 8:246. https:\/\/doi.org\/10.1038\/s41392-023-01450-3","journal-title":"Signal Transduct Target Ther"},{"key":"6382_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12964-024-01786-5","volume":"22","author":"X-N Ma","year":"2024","unstructured":"Ma X-N, Li M-Y, Qi G-Q, Wei L-N, Zhang D-K (2024) SUMOylation at the crossroads of gut health: insights into physiology and pathology. Cell Commun Signal 22:404. https:\/\/doi.org\/10.1186\/s12964-024-01786-5","journal-title":"Cell Commun Signal"},{"key":"6382_CR36","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/febs.15263","volume":"287","author":"A Nayak","year":"2020","unstructured":"Nayak A, Amrute\u2010Nayak M (2020) SUMO system\u2013a key regulator in sarcomere organization. FEBS J 287:2176\u20132190","journal-title":"FEBS J"},{"key":"6382_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101097","volume":"86","author":"S Pan","year":"2022","unstructured":"Pan S, Chen R (2022) Pathological implication of protein post-translational modifications in cancer. Mol Aspects Med 86:101097. https:\/\/doi.org\/10.1016\/j.mam.2022.101097","journal-title":"Mol Aspects Med"},{"key":"6382_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.gendis.2020.08.010","volume":"8","author":"Y Pan","year":"2021","unstructured":"Pan Y, Li Q, Cao Z, Zhao S (2021) The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses. Genes Dis 8:827\u2013837","journal-title":"Genes Dis"},{"key":"6382_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/tox.24049","volume":"39","author":"H Qin","year":"2024","unstructured":"Qin H, Yuan Y, Yuan M, Yi S, Yang Y, Zhang Y (2024) Tanshinone IIA ameliorates cisplatin-induced toxicology and cisplatin resistance via regulating SLC7A11 expression. Environ Toxicol 39:1429\u20131441. https:\/\/doi.org\/10.1002\/tox.24049","journal-title":"Environ Toxicol"},{"key":"6382_CR40","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.18632\/oncotarget.2197","volume":"5","author":"Y Ren","year":"2014","unstructured":"Ren Y, Liu K, Wang M, Yu Y, Yang K, Chen Q et al (2014) De-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells. Oncotarget 5:7093","journal-title":"Oncotarget"},{"key":"6382_CR41","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1038\/s41467-024-47751-1","volume":"15","author":"JS Rodrigues","year":"2024","unstructured":"Rodrigues JS, Chenlo M, Bravo SB, Perez-Romero S, Suarez-Fari\u00f1a M, Sobrino T et al (2024) dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe. Nat Commun 15:3736. https:\/\/doi.org\/10.1038\/s41467-024-47751-1","journal-title":"Nat Commun"},{"key":"6382_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/pld3.506","volume":"7","author":"TC Rytz","year":"2023","unstructured":"Rytz TC, Feng J, Barros JAS, Vierstra RD (2023) Arabidopsis-expressing lysine-null SUMO1 reveals a non-essential role for secondary SUMO modifications in plants. Plant Direct 7:e506","journal-title":"Plant Direct"},{"key":"6382_CR43","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/ijms23073639","volume":"23","author":"X Shi","year":"2022","unstructured":"Shi X, Du Y, Li S, Wu H (2022) The role of SUMO E3 ligases in signaling pathway of cancer cells. Int J Mol Sci 23:3639","journal-title":"Int J Mol Sci"},{"key":"6382_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12967-024-04913-5","volume":"22","author":"L Shi","year":"2024","unstructured":"Shi L, Shangguan J, Lu Y, Rong J, Yang Q, Yang Y et al (2024) ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression. J Transl Med 22:148. https:\/\/doi.org\/10.1186\/s12967-024-04913-5","journal-title":"J Transl Med"},{"key":"6382_CR45","doi-asserted-by":"crossref","unstructured":"Shkolnik D, Dey S, Hasan M, Matunis MJ, Brik A (2024) Chemical protein synthesis combined with protein cell delivery reveals new insights on the maturation process of SUMO2. Chem Sci","DOI":"10.1039\/D4SC06254J"},{"key":"6382_CR46","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.3390\/cancers13092059","volume":"13","author":"P Tokarz","year":"2021","unstructured":"Tokarz P, Wo\u017aniak K (2021) SENP proteases as potential targets for cancer therapy. Cancers (Basel) 13:2059","journal-title":"Cancers (Basel)"},{"key":"6382_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1042\/BST20190357","volume":"48","author":"N Varej\u00e3o","year":"2020","unstructured":"Varej\u00e3o N, Lascorz J, Li Y, Reverter D (2020) Molecular mechanisms in SUMO conjugation. Biochem Soc Trans 48:123\u2013135","journal-title":"Biochem Soc Trans"},{"key":"6382_CR48","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO (2022) Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol 23:715\u2013731","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6382_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13238-015-0216-7","volume":"7","author":"M Wang","year":"2016","unstructured":"Wang M, Sang J, Ren Y, Liu K, Liu X, Zhang J et al (2016a) SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2\/3-targeted ubiquitination and degradation. Protein Cell 7:63\u201377. https:\/\/doi.org\/10.1007\/s13238-015-0216-7","journal-title":"Protein Cell"},{"key":"6382_CR50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3892\/ol.2016.4729","volume":"12","author":"R Wang","year":"2016","unstructured":"Wang R, Liu H, Xu L, Zhang H, Zhou R (2016b) Melatonin downregulates nuclear receptor RZR\/ROR\u03b3 expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo. Oncol Lett 12:897\u2013903. https:\/\/doi.org\/10.3892\/ol.2016.4729","journal-title":"Oncol Lett"},{"key":"6382_CR51","first-page":"3828","volume":"15","author":"X Wang","year":"2018","unstructured":"Wang X, Wang L, Xu Y, Zhang G, Wu Y, Chen P (2018) PIAS1 inhibited the metastasis of gastric cancer cell by epithelial-mesenchymal transition regulation within the inflammatory microenvironment. Oncol Lett 15:3828\u20133837","journal-title":"Oncol Lett"},{"key":"6382_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.729211","volume":"9","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhong W, Deng L, Lin Q, Lin Y, Liu H et al (2021a) The expression and prognostic value of SUMO1-activating enzyme subunit 1 and its potential mechanism in triple-negative breast cancer. Front Cell Dev Biol 9:729211","journal-title":"Front Cell Dev Biol"},{"key":"6382_CR53","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41419-021-04302-6","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q, Xu C, Fan Q, Yuan H, Zhang X, Chen B et al (2021b) Positive feedback between ROS and cis-axis of PIASx\u03b1\/p38\u03b1-SUMOylation\/MK2 facilitates gastric cancer metastasis. Cell Death Dis 12:986. https:\/\/doi.org\/10.1038\/s41419-021-04302-6","journal-title":"Cell Death Dis"},{"key":"6382_CR54","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/cas.15618","volume":"114","author":"T Wang","year":"2023","unstructured":"Wang T, Min L, Gao Y, Zhao M, Feng S, Wang H et al (2023) SUMOylation of TUFT1 is essential for gastric cancer progression through AKT\/mTOR signaling pathway activation. Cancer Sci 114:533\u2013545. https:\/\/doi.org\/10.1111\/cas.15618","journal-title":"Cancer Sci"},{"key":"6382_CR55","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1038\/bjc.2014.231","volume":"110","author":"J Wei","year":"2014","unstructured":"Wei J, Costa C, Shen J, Yu L, Sanchez JJ, Qian X et al (2014) Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer. Br J Cancer 110:2662\u20132668. https:\/\/doi.org\/10.1038\/bjc.2014.231","journal-title":"Br J Cancer"},{"key":"6382_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s11658-024-00624-3","volume":"29","author":"B Wei","year":"2024","unstructured":"Wei B, Yang F, Yu L, Qiu C (2024) Crosstalk between SUMOylation and other post-translational modifications in breast cancer. Cell Mol Biol Lett 29:107","journal-title":"Cell Mol Biol Lett"},{"key":"6382_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122085","author":"W Wu","year":"2023","unstructured":"Wu W, Huang C (2023) SUMOylation and DeSUMOylation: prospective therapeutic targets in cancer. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.122085","journal-title":"Life Sci"},{"key":"6382_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1677\/jme.0.0320595","volume":"32","author":"Q Wu","year":"2004","unstructured":"Wu Q, Lin XF, Ye XF, Zhang B, Xie Z, Su WJ (2004) Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells. J Mol Endocrinol 32:595\u2013613. https:\/\/doi.org\/10.1677\/jme.0.0320595","journal-title":"J Mol Endocrinol"},{"key":"6382_CR59","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/bjc.2012.587","volume":"108","author":"W Wu","year":"2013","unstructured":"Wu W, Takanashi M, Borjigin N, Ohno SI, Fujita K, Hoshino S et al (2013) MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis. Br J Cancer 108:653\u2013661","journal-title":"Br J Cancer"},{"key":"6382_CR60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12964-024-01850-0","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Gu X, Weng W, Cheng J, Huang O, Pan S-J et al (2024) SUMOylation-induced membrane localization of TRPV1 suppresses proliferation and migration in gastric cancer cells. Cell Commun Signal 22:465. https:\/\/doi.org\/10.1186\/s12964-024-01850-0","journal-title":"Cell Commun Signal"},{"key":"6382_CR61","doi-asserted-by":"publisher","DOI":"10.1242\/dev.175703","volume":"147","author":"T-Y Yau","year":"2020","unstructured":"Yau T-Y, Molina O, Courey AJ (2020) SUMOylation in development and neurodegeneration. Development 147:dev175703","journal-title":"Development"},{"key":"6382_CR62","first-page":"1539","volume":"12","author":"M Zhang","year":"2019","unstructured":"Zhang M, Jiang D, Xie X, He Y, Lv M, Jiang X (2019) miR-129-3p inhibits NHEJ pathway by targeting SAE1 and represses gastric cancer progression. Int J Clin Exp Pathol 12:1539","journal-title":"Int J Clin Exp Pathol"},{"key":"6382_CR63","doi-asserted-by":"publisher","first-page":"9068","DOI":"10.1038\/s41467-024-53493-x","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ding T, Yang F, Zhang J, Xu H, Bai Y et al (2024) Peptidylprolyl isomerase A guides SENP5\/GAU1 DNA-lncRNA triplex generation for driving tumorigenesis. Nat Commun 15:9068. https:\/\/doi.org\/10.1038\/s41467-024-53493-x","journal-title":"Nat Commun"},{"key":"6382_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.701583","volume":"8","author":"W Zhao","year":"2021","unstructured":"Zhao W, Zhang X, Rong J (2021) SUMOylation as a therapeutic target for myocardial infarction. Front Cardiovasc Med 8:701583","journal-title":"Front Cardiovasc Med"},{"key":"6382_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.741736","volume":"9","author":"B Zhou","year":"2021","unstructured":"Zhou B, Zhu Y, Xu W, Zhou Q, Tan L, Zhu L et al (2021) Hypoxia stimulates SUMOylation-dependent stabilization of KDM5B. Front Cell Dev Biol 9:741736","journal-title":"Front Cell Dev Biol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06382-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T01:01:30Z","timestamp":1764464490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06382-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6382"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06382-9","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2"}}